🇺🇸 SECGSK plcQwen · 实盘不做把握 1/10不做原因:不是事件
北京时间·🕒 发布 08-26 22:37:48·⟳ 抓取 08-26 22:40:02 +2m14s·⚡ 决策 08-27 03:39:53 +4h59m·61.8 天前
GSK高管Maya Martinez-Davis在补充储蓄计划中获得9.221份名义ADS的例行披露
这是GSK高管在内部补充储蓄计划中获得9.221份名义ADS的例行PDMR披露，金额仅约$477，属行政性合规备案，无任何新增基本面信息、方向性含义或交易价值。Web/KB/行情均不可能改变这一判断。
📄 原文GSK plc↗ 原文
----- a2573s.htm ----- 6-K 1 a2573s.htm DIRECTOR/PDMR SHAREHOLDING a2573s UNITED STATES SECURITIES AND EXCHANGE COMMISS…
不做 GSK plc（GSK.US）
例行PDMR储蓄计划名义持仓披露（9.221份名义ADS，约$477），属行政合规备案，无方向性信息、无基本面增量、无交易价值
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
GSK 6-K披露美国区总裁Maya Martinez-Davis在GSK Executive Supplemental Savings Plan中获得9.221份名义ADS（$51.78/份，合计约$477）。此类储蓄计划内名义份额分配是被动行政动作，非高管自主买入信号，金额微乎其微，不反映任何基本面变化或管理层信心增量，属于典型的无交易价值例行披露。
🔎 新鲜度:最早出现 2026-08-26 · 扩散 low · price-in 风险 low ↗
先例如何影响了这次决策
对本次决策的影响:无先例需求——事件本身不构成交易催化
工具调用 · 历史记录,结果未知(1 种)
- fetch_decision_experience · 结果未知
原文全文
展开原文 · 2,295 字
----- a2573s.htm -----
6-K
1
a2573s.htm
DIRECTOR/PDMR SHAREHOLDING
a2573s
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the
month of August 2026
Commission
File Number 001-15170
GSK plc
(Translation
of registrant's name into English)
79 New Oxford Street, London, WC1A 1DG
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F . . . .X. . . . Form 40-F . . . . . . . .
GSK plc
(the
'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them
('PCA')
a)
Name
Maya Martinez-Davis
b)
Position/status
President, US
c)
Initial
notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
a)
Description
of the financial instrument
American Depositary Shares ('ADS')
ISIN: US37733W2044
b)
Nature
of the transaction
Acquisition of notional ADS within Ms Martinez-Davis's GSK
Executive Supplemental Savings Plan account
c)
Price(s)
and volume(s)
Price(s)
Volume(s)
$51.7800
9.221
d)
Aggregated
information
N/A (single transaction)
Aggregated
volume
Price
e)
Date
of the transaction
2026-08-24
f)
Place
of the transaction
New York Stock Exchange (XNYS)
About GSK
GSK is a global biopharma company with a purpose to unite science,
technology, and talent to get ahead of disease together. Find out
more at
www.gsk.com
.
Registered in England & Wales:
No.
3888792
Registered Office:
79
New Oxford Street
London
WC1A
1DG
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorised.
GSK plc
(Registrant)
Date: August
26, 2026
By:/s/ VICTORIA
WHYTE
--------------------------
Victoria Whyte
Authorised
Signatory for and on
behalf
of GSK plc
6-K
1
a2573s.htm
DIRECTOR/PDMR SHAREHOLDING
a2573s
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the
month of August 2026
Commission
File Number 001-15170
GSK plc
(Translation
of registrant's name into English)
79 New Oxford Street, London, WC1A 1DG
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F . . . .X. . . . Form 40-F . . . . . . . .
GSK plc
(the
'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them
('PCA')
a)
Name
Maya Martinez-Davis
b)
Position/status
President, US
c)
Initial
notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
a)
Description
of the financial instrument
American Depositary Shares ('ADS')
ISIN: US37733W2044
b)
Nature
of the transaction
Acquisition of notional ADS within Ms Martinez-Davis's GSK
Executive Supplemental Savings Plan account
c)
Price(s)
and volume(s)
Price(s)
Volume(s)
$51.7800
9.221
d)
Aggregated
information
N/A (single transaction)
Aggregated
volume
Price
e)
Date
of the transaction
2026-08-24
f)
Place
of the transaction
New York Stock Exchange (XNYS)
About GSK
GSK is a global biopharma company with a purpose to unite science,
technology, and talent to get ahead of disease together. Find out
more at
www.gsk.com
.
Registered in England & Wales:
No.
3888792
Registered Office:
79
New Oxford Street
London
WC1A
1DG
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorised.
GSK plc
(Registrant)
Date: August
26, 2026
By:/s/ VICTORIA
WHYTE
--------------------------
Victoria Whyte
Authorised
Signatory for and on
behalf
of GSK plc
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。